Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of British Columbia

$20,000.00

Integrated microfluidic platform for cell culture and characterization

FY 2012-13

Summary
In this interdisciplinary research program, a novel microfluidic system will be developed to culture, characterize, image, and screen cells within a single automated, portable platform, with large potential impact to improve health care. As a new paradigm for cell-based testing, this microscale platform promises to provide a simple, scalable tool to apply standardized protocols used in cellular response assays. One factor essential to obtaining meaningful data in either high-throughput drug screening during drug discovery, or in patient-specific screening, is to have a cell culture environment which recapitulates the in vivo environment. In contrast to the two-dimensional monolayer-based method of cell culture commonly used in molecular and cell biology, this approach will feature three-dimensional (3-D) cell culture, in which cells are embedded in a material that mimics the extracellular matrix. This research will combine this hydrogel-based method of culturing cells with on-chip microfluidic flow control for precise fluid handling. By integrating pumps and valves, along with arrays of nanoliter culture chambers, this work will enable several avenues of research: This work will develop integrated, microfabricated sensors, to monitor gradients such as oxygen concentration within the culture environment, which can contribute to variation in tumour response to treatment. We will investigate modified hydrogels to provide cell attachment points. Individual cells seeded into an array of chambers can form tumour-like aggregates, permitting studies of multicellular resistance. This system will enable controlled, repeated treatments and monitoring of the effects of therapeutic drugs on cultured cells, as well as co-culture of different cell types, to create more realistic in vitro tissue constructs. Modeling the tumour microenvironment would provide a base for development of microscale angiogenesis assays. Finally, this work would develop large-scale production of identical devices for parallel drug screening. The use of transparent materials allows the integration of these chips onto high-throughput imaging systems, with advantages in speed, cost, and efficiency.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
327361-2010
Name nom
Cheung, Karen
Department département
Electrical and Computer Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
3
Nb partie
5
Application title
Integrated microfluidic platform for cell culture and characterization
Keyword
NSERC
Application summary
In this interdisciplinary research program, a novel microfluidic system will be developed to culture, characterize, image, and screen cells within a single automated, portable platform, with large potential impact to improve health care. As a new paradigm for cell-based testing, this microscale platform promises to provide a simple, scalable tool to apply standardized protocols used in cellular response assays. One factor essential to obtaining meaningful data in either high-throughput drug screening during drug discovery, or in patient-specific screening, is to have a cell culture environment which recapitulates the in vivo environment. In contrast to the two-dimensional monolayer-based method of cell culture commonly used in molecular and cell biology, this approach will feature three-dimensional (3-D) cell culture, in which cells are embedded in a material that mimics the extracellular matrix. This research will combine this hydrogel-based method of culturing cells with on-chip microfluidic flow control for precise fluid handling. By integrating pumps and valves, along with arrays of nanoliter culture chambers, this work will enable several avenues of research: This work will develop integrated, microfabricated sensors, to monitor gradients such as oxygen concentration within the culture environment, which can contribute to variation in tumour response to treatment. We will investigate modified hydrogels to provide cell attachment points. Individual cells seeded into an array of chambers can form tumour-like aggregates, permitting studies of multicellular resistance. This system will enable controlled, repeated treatments and monitoring of the effects of therapeutic drugs on cultured cells, as well as co-culture of different cell types, to create more realistic in vitro tissue constructs. Modeling the tumour microenvironment would provide a base for development of microscale angiogenesis assays. Finally, this work would develop large-scale production of identical devices for parallel drug screening. The use of transparent materials allows the integration of these chips onto high-throughput imaging systems, with advantages in speed, cost, and efficiency.